Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
ILiAD Biotechnologies Plans Collaboration with Emmes Group, a New Mountain Capital Portfolio Company, for Phase III Clinical Trials of BPZE1, a Next-Generation Pertussis Vaccine
Tuesday, June 25, 2024ILiAD Biotechnologies LLC a biotechnology company focused on combating diseases caused by Bordetella
ANI Pharmaceuticals Plans to Expand Its Rare Disease Business by Acquiring Alimera Sciences
Tuesday, June 25, 2024ANI Pharmaceuticals Inc and Alimera Sciences Inc have announced a definitive agreement where ANI will acquire Alimera for per share in cash at closing along with a contingent value right
SK Bioscience and Sanofi Receive IND Approval for Phase 3 Global Clinical Trial of Next-Generation Pneumococcal Vaccine
Tuesday, June 25, 2024SK Bioscience and Sanofi have reached a significant milestone with the approval of the global Phase clinical trial plan for their valent pneumococcal conjugate vaccine candidate GBP
GSK's Omjjara (Momelotinib) Receives Approval in Japan for Treating Myelofibrosis
Tuesday, June 25, 2024GSK plc announced today that Omjjara has received approval from Japans Ministry of Health Labour and Welfare for treating myelofibrosis Omjjara is an oral inhibitor of JAKJAK and activin A receptor type
AstriVax Begins Clinical Trials for Innovative Vaccine Platform Technology
Monday, June 24, 2024AstriVax has commenced a Phase I clinical study to assess the safety and effectiveness of its prophylactic vaccines for yellow fever and rabies in healthy adults This initial human trial called SAFYR aims to provide essential safety and immunogenicit...
Roche Introduces Advanced Analytical Units for cobas® pro Integrated Solutions, Boosting Laboratory Efficiency and Capacity
Monday, June 24, 2024Roche has announced the launch of its latest analytical units the cobas c and cobas ISE neo under the cobas pro integrated solutions now available in countries that accept the CE mark
Bristol Myers Squibb Announces FDA Accelerated Approval of KRAZATI® (adagrasib) Combined with Cetuximab for KRAS G12C-Mutated Colorectal Cancer
Saturday, June 22, 2024Bristol Myers Squibb has received accelerated approval from the US Food and Drug Administration for KRAZATI in combination with cetuximab This new treatment targets adult patients
Sarepta Therapeutics Announces FDA Expansion of ELEVIDYS for Duchenne Muscular Dystrophy Patients Aged 4 and Up
Friday, June 21, 2024Sarepta Therapeutics Inc a leading company in precision genetic medicine for rare diseases has announced that the US Food and Drug Administration has expanded the indication for ELEVIDYS
SK Bioscience Introduces South Korea’s Inaugural AI-Driven Experiment Design System
Friday, June 21, 2024SK Bioscience is pioneering vaccine development through advanced AI technology Their new IT system ADO represents a major advancement in South Koreas
NephroDI Therapeutics Receives Investment from Sound Bioventures to Hasten Development of NDI-5001 for Pediatric Orphan Kidney Disease
Friday, June 21, 2024NephroDI Therapeutics a pharmaceutical company in the advanced stages of development focusing on kidney disorders has received a Series A investment from Sound Bioventures a life sciences venture
